2022 Q2 quarterly HIGHLIGHTS compared to the corresponding period of 2021: Revenues were $14.8 million , an increase of 4%, compared to $14.3 million Net income was $4.1 million , or $0.60 per basic share and $0.51 per diluted share, compared to $6.7 million , or $1.00 per basic share and $0.83
SANTA CLARA, Calif. , July 21, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and
2022 Q1 HIGHLIGHTS compared to the corresponding period of 2021: Revenues were $14.0 million , an increase of $0.8 million , or 6%, compared to $13.2 million Net income was $3.4 million , or $0.50 per basic share and $0.41 per diluted share, compared to $4.9 million , or $0.73 per basic share and
SANTA CLARA, Calif. , April 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended
SANTA CLARA, Calif. , April 7, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian , and chief
SANTA CLARA, Calif. , March 14, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its board of directors has authorized a $20.0 million stock
Results show a positive screening of previously undetected PAD was independently associated with short-term and long-term increased risks for mortality and major adverse cardiovascular events SANTA CLARA, Calif. , March 1, 2022 /PRNewswire/ -- Semler Scientific, Inc.
2021 HIGHLIGHTS compared to 2020: -- Annual revenues increased by 37% -- Net income increased by 23% -- Cash at December 31, 2021 increased to $37.3 million from $22.1 million SANTA CLARA, Calif. , Feb. 28, 2022 /PRNewswire/ -- Semler Scientific, Inc.
SANTA CLARA, Calif. , Feb. 17, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and
HIGHLIGHTS - Year-to-Date 2021 compared to the corresponding period of 2020: - Revenues were $41.5 million, an increase of 56% compared to $26.5 million - Pre-tax net income of $17.7 million, an increase of $7.7 million, or 77% compared to $10.0 million - Net income was $15.7 million, an increase
